Endocyte, Inc. News Headlines

ECYT 
$19.14
*  
0.79
 negative 
3.96%
Get ECYT Alerts
*Delayed - data as of Apr. 23, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

How Endocyte (ECYT) Stock Stands Out in a Strong Industry - Tale of the Tape
4/15/2014 8:36:01 AM - Zacks.com

Best- And Worst-Performing Stocks YTD
4/2/2014 10:13:00 AM - Seeking Alpha

Cramer's Lightning Round - Questcor: No Position, No Idea, And I'm Not Saying A Thing (3/31/14)
4/1/2014 5:42:00 AM - Seeking Alpha

Endocyte Prices New Offering at $21 Per Share - Analyst Blog
3/31/2014 4:30:01 PM - Zacks.com

Stock Pickers Rule - Weekend Wisdom
3/28/2014 12:39:01 PM - Zacks.com

Endocyte (ECYT) in Focus: Stock Tumbles 8.3% - Tale of the Tape
3/28/2014 8:47:01 AM - Zacks.com

Pre-Market Most Active for Mar 28, 2014 : BBRY, COMM, ARIA, ECYT, MNKD, WUBA, SIRI, BAC, SNE, HMC, VZ, NOK
3/28/2014 8:39:58 AM - NASDAQ.com News

OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals
3/25/2014 1:35:00 PM - Seeking Alpha

Endocyte (ECYT) Soars: Stock Adds 94.4% in Session - Tale of the Tape
3/24/2014 8:51:01 AM - Zacks.com

Endocyte Shares Soar As Cancer Drug Meets Main Goal In Mid Stage Study
3/21/2014 1:17:00 PM - RTT News

Healthcare Stocks Mixed at Mid-Day; Endocyte Nearly Doubles In Price On Chemotherapy Test Results
3/21/2014 1:11:39 PM - MT Newswires

Sector Update: Healthcare
3/21/2014 1:08:49 PM - MT Newswires

Endocyte Inc. (ECYT) Has Soared To A New High On Study Results
3/21/2014 9:34:00 AM - RTT News

Pre-Market Most Active for Mar 21, 2014 : BAC, BP, SYMC, SONS, ECYT, NOK, ASX, ERIC, KBH, FCEL, CHT, UPIP
3/21/2014 8:38:58 AM - NASDAQ.com News

Merck And Endocyte Announce CHMP Positive Opinions For Vynfinit - Quick Facts
3/21/2014 8:29:00 AM - RTT News

Endocyte To Present At Roth Conference; Webcast At 1:00 PM ET
3/10/2014 12:00:00 PM - RTT News

Endocyte To Present At Cowen And Co. Conference; Webcast At 8:40 AM ET
3/4/2014 7:40:00 AM - RTT News

Alcobra (ADHD) Jumps: Stock Rises 8.5% - Tale of the Tape
2/26/2014 10:04:01 AM - Zacks.com

Orphan Drug for Alexion's Soliris in EU - Analyst Blog
2/25/2014 7:05:01 PM - Zacks.com

Endocyte's Q4 Loss Narrower than Expected - Analyst Blog
2/25/2014 12:30:01 PM - Zacks.com

BIOL Has Reason To Smile, CBMG Walks The Talk, CLSN Warms Up, REGN Catches Eyes
2/25/2014 1:24:00 AM - RTT News

Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog
2/24/2014 6:20:01 PM - Zacks.com

Sector Update: Healthcare Stocks Flat to Higher Pre-Market; Pfizer Lifts 4% on Positive Results for Prevenar Study
2/24/2014 9:25:32 AM - MT Newswires

Sector Update: Healthcare
2/24/2014 9:25:16 AM - MT Newswires

Endocyte Q4 13 Earnings Conference Call At 8:30 AM ET
2/24/2014 7:30:00 AM - RTT News